Literature DB >> 1514038

Cells from healthy non-exposed individuals produce cytokines to selected fractions of Leishmania promastigotes.

K Maasho1, H O Akuffo.   

Abstract

We are interested in cellular responses to antigens of parasites to which the cell donor has not been previously exposed and how such responses may influence parasite establishment. In order to characterize such responses we have used cells from unexposed healthy donors and analysed the lymphoproliferative response to various Leishmania aethiopica antigen preparations and the cytokines produced in the process. Peripheral blood lymphocytes were stimulated with SDS-PAGE separated L. aethiopica antigen coupled to nitrocellulose particles. Fifteen of the 16 unexposed individuals tested had proliferative responses to either the whole or/and the antigen-bearing nitrocellulose fractions (NC fractions). Although the degree of response to the fractionated antigen varied in individuals, major stimulatory fractions were found in the high molecular weight region of 110-80 kDa (fractions 3-6) and low molecular weight region of 46-18 kDa (fractions 12-16). Substantial amounts of interferon gamma (IFN-gamma) and interleukin 2 (IL-2) were present in the supernatants of cells stimulated with the whole unfractionated antigen. The potential relevance of such responses in resistance to Leishmania infection is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1514038     DOI: 10.1111/j.1365-3083.1992.tb01647.x

Source DB:  PubMed          Journal:  Scand J Immunol Suppl        ISSN: 0301-6323


  10 in total

1.  Differential induction of cellular responses by live and dead Leishmania promastigotes in healthy donors.

Authors:  S Nylén; U Mörtberg; D Kovalenko; I Satti; K Engström; M Bakhiet; H Akuffo
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

2.  Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity.

Authors:  K Maasho; F Sanchez; E Schurr; A Hailu; H Akuffo
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  The contribution of the Fas/FasL apoptotic pathway in ulcer formation during Leishmania major-induced cutaneous Leishmaniasis.

Authors:  Liv Eidsmo; Susanne Nylen; Ali Khamesipour; Mari-Anne Hedblad; Francesca Chiodi; Hannah Akuffo
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

4.  Induction and abrogation of LACK reactive cells in the evolution of human leishmaniasis.

Authors:  K Maasho; D Wolday; M Edjigu; K Söderström; S Britton; H Akuffo
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

5.  Natural killer cells in cross-regulation of IL-12 by IL-10 in Leishmania antigen-stimulated blood donor cells.

Authors:  H Akuffo; A Alexis; L Eidsmo; A Saed; S Nylén; K Maasho
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

6.  Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma.

Authors:  S Nylén; K Maasho; K Söderstrom; T Ilg; H Akuffo
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

7.  Evaluation of amastigote reactive cells in human cutaneous leishmaniasis caused by Leishmania aethiopica.

Authors:  K Maasho; D McMahon-Pratt; J Raita; M Raud; S Britton; L Soong; H Akuffo
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

8.  Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation.

Authors:  T Lieke; S Nylén; L Eidsmo; W R McMaster; A M Mohammadi; A Khamesipour; L Berg; H Akuffo
Journal:  Clin Exp Immunol       Date:  2008-08       Impact factor: 4.330

9.  Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cells.

Authors:  H Akuffo; K Maasho; R Howe
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

10.  Th1-biased immunomodulation and therapeutic potential of Artemisia annua in murine visceral leishmaniasis.

Authors:  Mohammad Islamuddin; Garima Chouhan; Abdullah Farooque; Bilikere S Dwarakanath; Dinkar Sahal; Farhat Afrin
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.